Corrigendum to "Genotyping of eight polymorphic genes encoding drug-metabolizing enzymes and transporters using a customized oligonucleotide array" [Anal. Biochem. 360 (2007) 105-113] (DOI:10.1016/j.ab.2006.10.006);Genotyping of eight polymorphic genes encoding drug-metabolizing enzymes and transporters using a customized oligonucleotide array

Analytical Biochemistry

Volumn 360, Issue 1, 2007, Pages 105-113

  Lu, Yi ^a   Kow Yin Kham, Shirley ^a   Foo, Toon Chai ^a   Hany, Ariffin ^b   Quah, Thuan Chong ^a   Eng Juh Yeoh, Allen ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

Author keywords

Allele specific primer extension; Drug transporter; Drug metabolizing enzyme; Genetic polymorphism; Genotyping

Indexed keywords

ENCODING (SYMBOLS); ENZYMES; OLIGONUCLEOTIDES; PLANTS (BOTANY); POLYMERASE CHAIN REACTION; POLYMORPHISM; SCREENING; SIGNAL ENCODING;

DRUG TRANSPORTER; DRUG-METABOLIZING ENZYMES; GENETIC POLYMORPHISMS; GENOTYPING; SPECIFIC PRIMERS;

GENES;

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ABC TRANSPORTER; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; AZATHIOPRINE; CODEINE; CYTOCHROME P450 1A1; CYTOCHROME P450 2D6; DAUNORUBICIN; DEBRISOQUINE; DESIPRAMINE; DOXORUBICIN; ESTROGEN; ETACRYNIC ACID; ETOPOSIDE; GENOMIC DNA; GLUTATHIONE TRANSFERASE; MERCAPTOPURINE; METHOTREXATE; MITOMYCIN C; NEUROLEPTIC AGENT; NICOTINE; PHENACETIN; PREDNISONE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE; SPARTEINE; THIOPURINE METHYLTRANSFERASE; TIOGUANINE; UNINDEXED DRUG; VINCRISTINE;

ALLELE; ARTICLE; BLOOD SAMPLING; CAUCASIAN; CHINESE; DRUG METABOLISM; ENZYME ACTIVITY; FLUORESCENCE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; NEWBORN; NORMAL HUMAN; PHARMACOGENETICS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; UMBILICAL CORD BLOOD;

EID: 33845411004     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2007.04.027     Document Type: Erratum

References (49)

1. Senior P.A., and Bhopal R. Ethnicity as a variable in epidemiological research. Br. Med. J. 309 (1994) 327-330
2. Xie H.G., Kim R.B., Wood A.J., and Stein C.M. Molecular basis of ethnic differences in drug disposition and response. Annu. Rev. Pharmacol. Toxicol. 41 (2001) 815-850
3. Solus J.F., Arietta B.J., Harris J.R., Sexton D.P., Steward J.Q., McMunn C., Ihrie P., Mehall J.M., Edwards T.L., and Dawson E.P. Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. Pharmacogenomics 5 (2004) 895-931
4. Roses A.D. Pharmacogenetics and drug development: the path to safer and more effective drugs. Nat. Rev. Genet. 5 (2004) 645-656
5. Weinshilboum R., and Wang L. Pharmacogenomics: bench to bedside. Nat. Rev. Drug Discov. 3 (2004) 739-748
6. Collie-Duguid E.S., Pritchard S.C., Powrie R.H., Sludden J., Collier D.A., Li T., and McLeod H.L. The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations. Pharmacogenetics 9 (1999) 37-42
7. Kham S.K., Tan P.L., Tay A.H., Heng C.K., Yeoh A.E., and Quah T.C. Thiopurine methyltransferase polymorphisms in a multiracial Asian population and children with acute lymphoblastic leukemia. J. Pediatr. Hematol. Oncol. 24 (2002) 353-359
8. Gaedigk A., Tyndale R.F., Jurima-Romet M., Sellers E.M., Grant D.M., and Leeder J.S. NAD(P)H:quinone oxidoreductase: polymorphisms and allele frequencies in Caucasian, Chinese, and Canadian Native Indian and Inuit populations. Pharmacogenetics 8 (1998) 305-313
9. Inoue K., Asao T., and Shimada T. Ethnic-related differences in the frequency distribution of genetic polymorphisms in the CYP1A1 and CYP1B1 genes in Japanese and Caucasian populations. Xenobiotica 30 (2000) 285-295
10. Enokida H., Shiina H., Urakami S., Igawa M., Ogishima T., Pookot D., Li L.C., Tabatabai Z.L., Kawahara M., Nakagawa M., Kane C.J., Carroll P.R., and Dahiya R. Ethnic group-related differences in CpG hypermethylation of the GSTP1 gene promoter among African-American, Caucasian, and Asian patients with prostate cancer. Intl. J. Cancer 116 (2005) 174-181
11. Ogino S., and Wilson R.B. Genotype and haplotype distributions of MTHFR677C > T and 1298A > C single nucleotide polymorphisms: a meta-analysis. J. Hum. Genet. 48 (2003) 1-7
12. Balram C., Sharma A., Sivathasan C., and Lee E.J. Frequency of C3435T single nucleotide MDR1 genetic polymorphism in an Asian population: phenotypic-genotypic correlates. Br. J. Clin. Pharmacol. 56 (2003) 78-83
13. Krajinovic M., Labuda D., Mathonnet G., Labuda M., Moghrabi A., Champagne J., and Sinnett D. Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes, DNA repair enzymes, and response to treatment of childhood acute lymphoblastic leukemia. Clin. Cancer Res. 8 (2002) 802-810
14. Krajinovic M., Lamothe S., Labuda D., Lemieux-Blanchard E., Theoret Y., Moghrabi A., and Sinnett D. Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Blood 103 (2004) 252-257
15. Laverdiere C., Chiasson S., Costea I., Moghrabi A., and Krajinovic M. Polymorphism G80A in the reduced folate carrier gene and its relationship to methotrexate plasma levels and outcome of childhood acute lymphoblastic leukemia. Blood 100 (2002) 3832-3834
16. Nei M., and Roychoudhury A.K. Evolutionary relationships of human populations on a global scale. Mol. Biol. Evol. 10 (1993) 927-943
17. Barnabas S., Joshi B., and Suresh C.G. Indian-Asian relationship: mtDNA reveals more. Naturwissenschaften 87 (2000) 180-183
18. Yao Y.G., Watkins W.S., and Zhang Y.P. Evolutionary history of the mtDNA 9-bp deletion in Chinese populations and its relevance to the peopling of east and southeast Asia. Hum. Genet. 107 (2000) 504-512
19. Ismail R., Teh L.K., Amir J., Alwi Z., and Lopez C.G. Genetic polymorphism of CYP2D6 in Chinese subjects in Malaysia. J. Clin. Pharm. Ther. 28 (2003) 279-284
20. Kitada M. Genetic polymorphism of cytochrome P450 enzymes in Asian populations: focus on CYP2D6. Intl. J. Clin. Pharmacol. Res. 23 (2003) 31-35
21. Chowbay B., Zhou S., and Lee E.J. An interethnic comparison of polymorphisms of the genes encoding drug-metabolizing enzymes and drug transporters: experience in Singapore. Drug Metab. Rev. 37 (2005) 327-378
22. Krajinovic M., Sinnett H., Richer C., Labuda D., and Sinnett D. Role of NQO1, MPO, and CYP2E1 genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Intl. J. Cancer 97 (2002) 230-236
23. Chango A., Emery-Fillon N., de Courcy G.P., Lambert D., Pfister M., Rosenblatt D.S., and Nicolas J.P. A polymorphism (80G- > A) in the reduced folate carrier gene and its associations with folate status and homocysteinemia. Mol. Genet. Metab. 70 (2000) 310-315
24. Adonis M., Martinez V., Marin P., and Gil L. CYP1A1 and GSTM1 genetic polymorphisms in lung cancer populations exposed to arsenic in drinking water. Xenobiotica 35 (2005) 519-530
25. Gajecka M., Rydzanicz M., Jaskula-Sztul R., Kujawski M., Szyfter W., and Szyfter K. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1, and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma. Mutat. Res. 574 (2005) 112-123
26. Patsopoulos N.A., Ntzani E.E., Zintzaras E., and Ioannidis J.P. CYP2D6 polymorphisms and the risk of tardive dyskinesia in schizophrenia: a meta-analysis. Pharmacogenet. Genom. 15 (2005) 151-158
27. Esfandiary H., Chakravarthy U., Patterson C., Young I., and Hughes A.E. Association study of detoxification genes in age related macular degeneration. Br. J. Ophthalmol. 89 (2005) 470-474
28. Sobti R.C., Al-Badran A.I., Sharma S., Sharma S.K., Krishan A., and Mohan H. Genetic polymorphisms of CYP2D6, GSTM1, and GSTT1 genes and bladder cancer risk in north India. Cancer Genet. Cytogenet. 156 (2005) 68-73
29. Stanulla M., Schaeffeler E., Flohr T., Cario G., Schrauder A., Zimmermann M., Welte K., Ludwig W.D., Bartram C.R., Zanger U.M., Eichelbaum M., Schrappe M., and Schwab M. Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia. JAMA 293 (2005) 1485-1489
30. Kurzawski M., Dziewanowski K., Gawronska-Szklarz B., Domanski L., and Drozdzik M. The impact of thiopurine S-methyltransferase polymorphism on azathioprine-induced myelotoxicity in renal transplant recipients. Ther. Drug Monit. 27 (2005) 435-441
31. Kurzawski M., Dziewanowski K., Ciechanowski K., and Drozdzik M. Severe azathioprine-induced myelotoxicity in a kidney transplant patient with thiopurine S-methyltransferase-deficient genotype (TPMT*3A/*3C). Transpl. Intl. 18 (2005) 623-625
32. Breen D.P., Marinaki A.M., Arenas M., and Hayes P.C. Pharmacogenetic association with adverse drug reactions to azathioprine immunosuppressive therapy following liver transplantation. Liver Transpl. 11 (2005) 826-833
33. Lewis A.M., Ough M., Hinkhouse M.M., Tsao M.S., Oberley L.W., and Cullen J.J. Targeting NAD(P)H:quinone oxidoreductase (NQO1) in pancreatic cancer. Mol. Carcinog. 43 (2005) 215-224
34. Saldivar S.J., Wang Y., Zhao H., Shao L., Lin J., Spitz M.R., and Wu X. An association between a NQO1 genetic polymorphism and risk of lung cancer. Mutat. Res. 582 (2005) 71-78
35. Niwa Y., Hirose K., Nakanishi T., Nawa A., Kuzuya K., Tajima K., and Hamajima N. Association of the NAD(P)H:quinone oxidoreductase C609T polymorphism and the risk of cervical cancer in Japanese subjects. Gynecol. Oncol. 96 (2005) 423-429
36. Lanciotti M., Dufour C., Corral L., Di Michele P., Pigullo S., De Rossi G., Basso G., Leszl A., Luciani M., Lo Nigro L., Micalizzi C., Valsecchi M.G., Biondi A., and Haupt R. Genetic polymorphism of NAD(P)H:quinone oxidoreductase is associated with an increased risk of infant acute lymphoblastic leukemia without MLL gene rearrangements. Leukemia 19 (2005) 214-216
37. Srivastava D.S., Mishra D.K., Mandhani A., Mittal B., Kumar A., and Mittal R.D. Association of genetic polymorphism of glutathione S-transferase M1, T1, P1, and susceptibility to bladder cancer. Eur. Urol. 48 (2005) 339-344
38. Ertunc D., Aban M., Tok E.C., Tamer L., Arslan M., and Dilek S. Glutathione-S-transferase P1 gene polymorphism and susceptibility to endometriosis. Hum. Reprod. 20 (2005) 2157-2161
39. Chan Q.K., Khoo U.S., Ngan H.Y., Yang C.Q., Xue W.C., Chan K.Y., Chiu P.M., Ip P.P., and Cheung A.N. Single nucleotide polymorphism of pi-class glutathione S-transferase and susceptibility to endometrial carcinoma. Clin. Cancer Res. 11 (2005) 2981-2985
40. Stanulla M., Schaffeler E., Arens S., Rathmann A., Schrauder A., Welte K., Eichelbaum M., Zanger U.M., Schrappe M., and Schwab M. GSTP1 and MDR1 genotypes and central nervous system relapse in childhood acute lymphoblastic leukemia. Intl. J. Hematol. 81 (2005) 39-44
41. Kurzawski M., Drozdzik M., Suchy J., Kurzawski G., Bialecka M., Gornik W., and Lubinski J. Polymorphism in the P-glycoprotein drug transporter MDR1 gene in colon cancer patients. Eur. J. Clin. Pharmacol. 61 (2005) 389-394
42. Tan E.K., Chan D.K., Ng P.W., Woo J., Teo Y.Y., Tang K., Wong L.P., Chong S.S., Tan C., Shen H., Zhao Y., and Lee C.G. Effect of MDR1 haplotype on risk of Parkinson disease. Arch. Neurol. 62 (2005) 460-464
43. Roberts R.L., Joyce P.R., Mulder R.T., Begg E.J., and Kennedy M.A. A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depression. Pharmacogenomics J. 2 (2002) 191-196
44. Zhang L., Taub J.W., Williamson M., Wong S.C., Hukku B., Pullen J., Ravindranath Y., and Matherly L.H. Reduced folate carrier gene expression in childhood acute lymphoblastic leukemia: relationship to immunophenotype and ploidy. Clin. Cancer Res. 4 (1998) 2169-2177
45. Relton C.L., Wilding C.S., Jonas P.A., Lynch S.A., Tawn E.J., and Burn J. Genetic susceptibility to neural tube defect pregnancy varies with offspring phenotype. Clin. Genet. 64 (2003) 424-428
46. Hirose M., Kono S., Tabata S., Ogawa S., Yamaguchi K., Mineshita M., Hagiwara T., Yin G., Lee K.Y., Tsuji A., and Ikeda N. Genetic polymorphisms of methylenetetrahydrofolate reductase and aldehyde dehydrogenase 2, alcohol use, and risk of colorectal adenomas: Self-Defense Forces Health Study. Cancer Sci. 96 (2005) 513-518
47. Deligezer U., Akisik E.E., and Dalay N. Homozygosity at the C677T of the MTHFR gene is associated with increased breast cancer risk in the Turkish population. In Vivo 19 (2005) 889-893
48. Oliveira E., Alves S., Quental S., Ferreira F., Norton L., Costa V., Amorim A., and Prata M.J. The MTHFR C677T and A1298C polymorphisms and susceptibility to childhood acute lymphoblastic leukemia in Portugal. J. Pediatr. Hematol. Oncol. 27 (2005) 425-429
49. Wang B., Jin F., Kan R., Ji S., Zhang C., Lu Z., Zheng C., Yang Z., and Wang L. Association of MTHFR gene polymorphism C677T with susceptibility to late-onset Alzheimer's disease. J. Mol. Neurosci. 27 (2005) 23-28